According to a market report by Lucintel, the future of the global zebrafish market looks promising with opportunities in the pharmaceutical, biotechnology, agrochemical research, cosmetic, and water quality monitoring markets. The global zebrafish market is expected to grow with a CAGR of 13.2% from 2024 to 2030. The major drivers for this market are growing demand for zebrafish models in biomedical research and increasing application of zebrafish in toxicology and disease modeling studies.

A more than 150 – page report is developed to understand Trends, opportunity and forecast in zebrafish market to 2030 by type (toxicity testing service, transgenesis & gene editing service, disease model, and others), application (pharmaceutical, biotechnology, agrochemical research, cosmetics, water quality monitoring, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

In this market, toxicity testing service, transgenesis & gene editing service, and disease model are the major segments of zebrafish market by type. Lucintel forecasts that toxicity testing service is expected to witness the highest growth.

Within this market, pharmaceutical is expected to witness the highest growth.

Download sample by clicking on zebrafish market

APAC is expected to witness highest growth.

Shanghai Model Organisms Center, Biobide, InVivo Biosystems, Evotec, ZEclinics, Aurigene Pharmaceutical Services, Ikanbiotech, Pentagrit, YSY Biotech, and Bioreperia are the major suppliers in the zebrafish market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com